A pilot: efficacy and safety of using combination of microneedle radiofrequency combination with polynucleotides compared with fractional microneedle radiofrequency for the treatment of melasma in Asians
- Conditions
- melasma
- Registration Number
- TCTR20210804002
- Lead Sponsor
- IDS Medical Systems (Thailand) Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1. having melasma both cheeks
2. older than or 18 years old
Exclusion Criteria
1. history of allergy of anestheic cream
2. history of allergy of polypeptide serum
3. history of infection at face
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method darkness at 1, 2, 3, 6 months after treatment mexameter,Melasma area and severity socre at 1, 2, 3, 6 months after treatment masi score
- Secondary Outcome Measures
Name Time Method Average melanin at 1, 2, 3, 6 months after treatment Antera,Patient improvement score at 1, 2, 3, 6 months after treatment Quartile scale,Physician improvement score at 1, 2, 3, 6 months after treatment Quartile scale